Home         Forums  

Go Back   Marrowforums > Treatments > Transfusions and Iron Overload
Register FAQ Search Today's Posts Mark Forums Read

Transfusions and Iron Overload Blood and platelet transfusions, iron testing and treatments

Thread Tools Search this Thread
Old Sun Dec 12, 2010, 03:10 PM
akita akita is offline
Join Date: Nov 2010
Posts: 110
ASH 2010 Who should be treated wih ICT after SZT ?


3444 Prognostic Impact of Posttransplantation Serum Ferritin In Allogeneic Stem Cell Transplantation for Leukemia or Myelodysplastic Syndrome

This Japanese study evaluated the impact of the post-transplantation iron overload in 107 patients after allogeneic SZT."

There were included only people in the study who survived 1 year or longer.

The patients formed two groups with pretransplantation Ferritin < 1000 ng/ml - low, and >= 1000 ng/ml - high.
"There was no significant difference between the low and high pretransplantation ferritin groups with respect to 5-year overall survival"

"Patients receiving more than 6 units of RBC (after SZT, akita) had significantly higher serum ferritin levels from 1 to 3 years after SCT. Patients with chronic graft-versus-host disease (cGVHD) showed significantly higher serum ferritin levels from 2 to 4 years after SCT compared to patients without chronic GVHD."

A high ferritin after SCT was independently associated with worse 5-year OS and also with worse 5-year desease-free survival by multivariate analysis

Citation: "These results might help to decide which patients should be treated with iron chelating therapy after SCT."
Margarete, 54, living in Vienna, Austria,
MDS/AML M2, diagnosed 9/2007, then Chemos, aSZT 4/2008, chronic GVHD
Reply With Quote

Thread Tools Search this Thread
Search this Thread:

Advanced Search

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

vB code is On
Smilies are On
[IMG] code is On
HTML code is Off
Forum Jump

Similar Threads
Thread Thread Starter Forum Replies Last Post
ASH 2010 Lenalidomide in MDS with Karyotypes other than del 5q and Refractory to ESAs akita News and Events 0 Thu Dec 16, 2010 02:25 PM
ASH 2010 Splenectomy in Patients with MDS akita MDS 0 Thu Dec 16, 2010 01:46 PM
ASH 2010 ICT with DFX in Transfusion Dependent MDS akita Transfusions and Iron Overload 0 Wed Dec 15, 2010 05:51 PM
ASH 2010 Deferasirox does not appear to interfere with Cyclosporin akita Transfusions and Iron Overload 0 Fri Dec 10, 2010 04:52 PM
ASH 2010 Hematologic Responses in MDS Patients - Deferasirox/Exjade akita Transfusions and Iron Overload 0 Fri Dec 10, 2010 04:14 PM

All times are GMT -4. The time now is 08:56 PM.

Powered by vBulletin® Version 3.6.7
Copyright ©2000 - 2020, Jelsoft Enterprises Ltd.
Forum sites may contain non-authoritative and unverified information.
Medical decisions should be made in consultation with qualified medical professionals.
Site contents exclusive of member posts Copyright 2006-2020 Marrowforums.org